Highlight
– Increasing patient age at ACL reconstruction correlates with distinct synovial fluid biomarker alterations, particularly decreased TIMP-1 concentrations.
– Age modulates biomarker-outcome associations influencing long-term pain, function, and activity levels after ACL injury.
– Elevated inflammatory markers like MIP-1β and MMP-3 predict poorer outcomes in an age-dependent manner.
– Incorporating age in biomarker interpretation can refine prognostication and personalize post-ACL injury management.
Study Background
Specialty calculators
For clinical reference; use professional judgment.
